![]() |
市場調查報告書
商品編碼
2035354
工業外骨骼市場預測至2034年—按類型、組件、移動性、應用、最終用戶和地區分類的全球分析Industrial Exoskeletons Market Forecasts to 2034 - Global Analysis By Type, Component, Mobility, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球工業外骨骼市場規模將達到 18 億美元,並在預測期內以 15.2% 的複合年成長率成長,到 2034 年將達到 56 億美元。
工業外骨骼是指穿戴式的機械和機電裝置,包括被動式、非動力支撐結構、動力輔助系統、上肢承重外骨骼、下肢活動輔助外骨骼、全身整合系統和電子機械外骨骼。這些裝置透過減輕肌肉骨骼壓力、輔助搬運重物、提高運動耐力,以及使工人能夠在製造業、物流業、建築業、農業和軍事應用領域中以更低的受傷風險完成體力勞動,從而補充或增強工人的身體能力。
製造業工人因人體工學相關傷害所造成的成本
製造業、物流業和建築業因肌肉骨骼疾病導致的職場成本(包括勞工賠償、生產力下降、醫療費用等)促使各大公司投資工業外骨骼項目,將其作為工傷預防技術。經驗表明,佩戴外骨骼的組裝和物料輸送工人上肢和下背部損傷的發生率顯著降低。此外,政府職業安全法規強制要求實施符合人體工學的危害降低計劃,這進一步獎勵企業採用工業外骨骼,而不僅僅是出於降低工傷成本的經濟動機。
工人的接受度與行為抵制
在引入工業外骨骼的過程中,與工人接受度相關的挑戰——例如設備重量、熱舒適度限制、活動範圍受限、適應期內對生產力影響的擔憂,以及對職場造成身體限制的技術的心理抵觸——都會在實施過程中造成重大阻力。因此,除非外骨骼推廣舉措有獎勵機制,以促進工人的全面參與、最佳化舒適度並鼓勵自願採用,否則其營運利用率將低於計畫投資預期。
針對老化勞動力的拓展計劃
在日本、德國、韓國和美國,製造業勞動人口老化,加上經驗豐富的工人退休可能導致生產技術流失,促使雇主投資外骨骼,將其作為一種「勞動力延伸技術」。外骨骼透過符合人體工學的支撐,使老年工人能夠在超過傳統退休年齡後繼續從事體力勞動強度大的生產工作。這體現了一種勞動力策略的應用,需要雇主做出強力的投資承諾,而不僅僅是出於預防工傷的投資報酬率計算。
透過自動化與替代技術競爭
協作機器人、自動導引運輸車)以及自動化輸送機和升降系統的日益普及——這些技術取代而非補充了體力勞動強度大的人工——正成為製造和物流企業採用外骨骼的根本性競爭對手。這是因為與永續勞動力增強計劃中外骨骼硬體所需的持續維護、培訓和合規項目相比,這些技術透過完全自動化任務提供了更優的長期營運經濟效益。
新冠疫情導致製造業勞動力短缺,使得企業迫切需要提升員工能力,並加大對改善工人安全的投入,這最初加速了大型汽車和物流公司對外部骨骼專案的評估和試點部署。疫情後製造業勞動市場的緊縮,加上人們對增強體能價值的日益重視,以及成熟的外部骨骼部署項目所取得的減少工傷、提高生產效率等成效,持續推動著工業外部骨骼在全球製造業的市場應用。
在預測期內,全身外骨骼細分市場預計將佔據最大的市場佔有率。
預計在預測期內,全身外骨骼細分市場將佔據最大的市場佔有率。這是因為它可以同時支撐上半身、下半身和身體軀幹,在各種需要減輕全身負荷的製造和物流作業中,能夠提供最大的人體工學優勢。儘管與專注於單一身體部位的設備相比,全身外骨骼的部署數量較少,但預計它將成為工業外骨骼市場中貢獻最大收入的細分市場。
預計在預測期內,硬體領域將呈現最高的複合年成長率。
在預測期內,硬體領域預計將呈現最高的成長率。這主要得益於工業外骨骼在汽車組裝、物流倉儲和建築等行業的快速商業化應用,隨著專案從最初的試驗計畫擴展到企業範圍內的員工部署,硬體採購量將顯著增加。此外,外骨骼機械設計的日趨成熟和製造成本的降低,將使價格更加親民,並推動其應用範圍從大型企業試驗計畫擴展到中型企業。
在預測期內,北美預計將佔據最大的市場佔有率。這是因為美國擁有全球最活躍的工業外骨骼商業部署生態系統,Ekso Bionics、Sarcos 和 Levitate Technologies 等領先公司透過與汽車和物流行業的夥伴關係項目獲得了可觀的國內收入,美國職業安全與健康管理局 (OSHA) 的相關法規也促使企業積極遵守人體工學風險法規,此外,高昂的人事費用等經濟因素也推高了外骨骼工程學的投資回報率 (ROI)。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要歸因於以下幾個因素:日本實施了全球最積極的政府支持的外骨骼項目,以應對勞動力老齡化問題;韓國現代汽車公司在外骨骼研發和商業化方面處於領先地位;中國製造業對外骨骼技術的快速應用;以及亞太各國政府對工業機器人和人類增強技術的巨額投資,這些因素共同推動了區域市場的發展勢頭。
According to Stratistics MRC, the Global Industrial Exoskeletons Market is accounted for $1.8 billion in 2026 and is expected to reach $5.6 billion by 2034 growing at a CAGR of 15.2% during the forecast period. Industrial exoskeletons refer to wearable mechanical and electromechanical devices including passive non-powered support structures, powered motorized assistance systems, upper body load-bearing exoskeletons, lower body mobility support exoskeletons, full body integrated systems, and soft exosuits that supplement or amplify human worker physical capability by reducing musculoskeletal strain, supporting heavy load carrying, augmenting movement endurance, and enabling workers to perform physically demanding tasks with reduced injury risk in manufacturing, logistics, construction, agriculture, and military applications.
Manufacturing Workforce Ergonomic Injury Costs
Substantial manufacturing, logistics, and construction sector musculoskeletal disorder workplace injury costs including workers' compensation claims, lost productivity, and healthcare expenses are compelling large employers to invest in industrial exoskeleton programs as injury prevention technology with documented reduction in upper extremity and lower back injury incidence among exoskeleton-wearing assembly and material handling workers. Government occupational safety regulations mandating ergonomic hazard mitigation programs create additional institutional adoption incentives beyond pure economic injury cost reduction motivation.
Worker Acceptance Behavioral Resistance
Industrial exoskeleton worker acceptance challenges arising from device weight, thermal comfort limitations, range of motion restriction, perceived productivity impact during adaptation periods, and psychological resistance to workplace technology imposing physical constraints create substantial adoption friction that reduces operational utilization rates below program investment assumptions unless comprehensive worker engagement, comfort optimization, and voluntary adoption incentive programs accompany exoskeleton deployment initiatives.
Aging Workforce Extension Programs
Aging manufacturing workforce demographics in Japan, Germany, South Korea, and the United States where experienced worker retirement risk threatens production knowledge loss are creating institutional employer motivation for exoskeleton investment as workforce extension technology enabling older workers to continue physically demanding production roles beyond conventional retirement age through exoskeleton-assisted ergonomic support, representing a workforce strategy application commanding strong employer investment commitment beyond pure injury prevention ROI calculation.
Automation Substitution Technology Competition
Expanding deployment of collaborative robots, autonomous guided vehicles, and automated conveyor and lift systems that eliminate rather than augment physically demanding human tasks represents a structural competitive alternative to exoskeleton adoption for manufacturing and logistics operators who can achieve superior long-term operational economics through full task automation compared to continuous exoskeleton hardware maintenance, training, and compliance program investment required for sustained workforce augmentation programs.
COVID-19 manufacturing labor availability constraints creating workforce augmentation urgency and worker safety enhancement investment motivation generated initial accelerated exoskeleton program evaluation and pilot deployment programs among major automotive and logistics operators. Post-pandemic manufacturing labor market tightening making physical capability augmentation more valuable combined with growing evidence from mature exoskeleton deployment programs demonstrating injury reduction and productivity outcomes continue driving industrial exoskeleton market adoption momentum across global manufacturing sectors.
The Full Body Exoskeletons segment is expected to be the largest during the forecast period
The Full Body Exoskeletons segment is expected to account for the largest market share during the forecast period, due to the highest per-unit commercial value of integrated full body exoskeleton systems providing simultaneous upper extremity, lower body, and trunk support for maximum ergonomic benefit across diverse manufacturing and logistics task types that require whole-body physical demand reduction, generating the highest segment revenue contribution within the industrial exoskeleton market despite lower unit deployment volume compared to single-body-region specialized devices.
The Hardware segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Hardware segment is predicted to witness the highest growth rate, driven by rapid expansion of industrial exoskeleton commercial deployments across automotive assembly, logistics warehousing, and construction applications creating substantial hardware procurement volumes as program scale-up progresses from initial pilot programs to enterprise-wide workforce deployment, combined with manufacturing cost reduction from maturing exoskeleton mechanical design enabling more accessible commercial pricing that expands adoption beyond large enterprise pilot programs to mid-size employer deployment.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's most active industrial exoskeleton commercial deployment ecosystem with leading companies including Ekso Bionics, Sarcos, and Levitate Technologies generating substantial domestic revenue from automotive and logistics sector partnership programs, strong OSHA regulatory ergonomic hazard compliance motivation, and high labor cost economics strengthening exoskeleton investment return calculations.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to Japan implementing the most active government-supported exoskeleton workforce aging extension programs in the world, South Korea hosting leading exoskeleton research and commercialization from Hyundai Motor Company, rapidly growing Chinese manufacturing sector adoption, and substantial Asia Pacific government investment in industrial robotics and human augmentation technology generating regional market momentum.
Key players in the market
Some of the key players in Industrial Exoskeletons Market include Ekso Bionics Holdings Inc., SuitX (Ottobock), Cyberdyne Inc., Sarcos Technology and Robotics Corporation, Honda Motor Co. Ltd., Hyundai Motor Company, Lockheed Martin Corporation, Panasonic Corporation, Festo AG, Comau S.p.A., Noonee AG, Levitate Technologies Inc., Laevo BV, German Bionic Systems GmbH, RB3D, Mawashi Science & Technology, and B-Temia Inc..
In March 2026, Sarcos Technology and Robotics Corporation launched its Guardian XO full body powered exoskeleton commercial subscription service targeting automotive and aerospace manufacturing customers with monthly per-unit pricing eliminating upfront hardware capital investment barriers.
In February 2026, German Bionic Systems GmbH introduced the Apogee Plus powered back support exoskeleton with integrated AI gait analysis providing real-time personalized support adjustment for individual worker movement patterns in logistics and manufacturing applications.
In November 2025, Levitate Technologies Inc. secured a major automotive supplier contract deploying its AIRFRAME passive upper extremity exoskeleton across 500 overhead assembly workstations following clinical ergonomic study validating significant shoulder fatigue reduction.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.